Precision Medicine Europe 2027
Congress Centre Basel, Switzerland
See what's coming, earlier.
The Investment Forum at Precision Medicine Europe brings Europe's precision medicine ecosystem into one room for a focused session on deal flow. In Basel, scientifically credible early-stage biotech and biopharma companies meet active life science investors and pharma business development teams, with a focus on Seed, Series A and early Series B opportunities.
Who takes part
Founders
Early-stage companies from across Europe working in biomarkers, precision diagnostics and CDx, multimodal omics, clinical development, and AI and data platforms. Selected companies pitch for 7 minutes, followed by 3 minutes of questions.
Investors
Venture capital, angel and corporate investors backing European life science at Seed to early Series B. Watch vetted companies pitch, hear peers on the investor panels, and meet founders one-to-one.
Pharma Busines Development Teams
Partnering and licensing teams looking across Europe for their next external innovation. Hear the pitches and meet the founders whose technologies could become your next deal.
How the Forum Runs
- Startup Zone pitches: first round
- Lunch and networking
- Startup Zone pitches: second round
- Panel: Building Investor Confidence on AI in Precision Medicine
- Panel: Where Investors See Opportunity in Drug Development & Precision Medicine
- Break
- Presentation: What are Investors Looking for in 2027?
- One-on-one networking
Running order is provisional. Timings and details to be confirmed.*


Why take part
- See European deal flow in one session: from early science to clinical application, across biomarkers, diagnostics, omics and data.
- Meet founders and their future partners together: investors and pharma teams in the same room as the companies they’re assessing.
- Trust the quality: companies and investors are qualified for fit, funding stage, scientific credibility, investment criteria and investor readiness.
- Hear where the money's going: panels and a presentation on what investors are looking for in 2027.
Why Basel
Biomarkers, CDx & Precision Medicine Europe and NextGen Omics, Tech & Data have become Precision Medicine Europe. That puts founders in front of biomarker, diagnostics, omics, pathology and data leaders from across Europe in one place, alongside the investors looking for what comes next. Basel is one of Europe's leading life science centres, and the Forum gives early-stage companies a direct route to the people who can fund and partner with them.

How to Take Part
For Founders:
Register your interest and tell us how you’d like to take part: pitching, joining a panel, networking or a mix. The Forum opens with pitches from Startup Zone companies. Start-ups that aren’t vendors attend Precision Medicine Europe free; exhibiting in the Startup Zone is a paid package.
For Investors and Pharma Partners:
Register your interest and let us know whether you’d like to join a panel, present or network. There’s no cost for investors, and some are invited directly.
Frequently Asked Questions
What happens in the Investment Forum at Precision Medicine Europe?
The pitches are followed by investor panels, a presentation on what investors are looking for in 2027, and one-to-one networking.
When is the Investment Forum at Precision Medicine Europe?
Which companies can pitch in the Investment Forum?
Scientifically credible early-stage biotech and biopharma companies at Seed to early Series B, working across precision medicine and drug development.
Register your interest and the team will be in touch.
Is there a cost for the Investment Forum at Precision Medicine Europe?
How does the Investment Forum connect to the Startup Zone at Precision Medicine Europe?
The Forum opens with pitches from Startup Zone companies. See the Startup Zone at Precision Medicine Europe.
Pharma Focus Europe
Pharma Focus Europe is a Bi-annual magazine from Ochre Media. It is the leading Pharma title in digital versions serving the information needs of key executives from the world's leading Pharma providers. Pharma Focus Europe covers important issues and trends shaping the future of the Pharma industry across Europe and rest of the world. It offers dedicated, reliable and accurate coverage of the industry's progress and incisive analysis to help its readers make informed decisions to stay ahead of the competition.
